BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program
DUBLIN, Feb. 3, 2020 |PRNewswire| -- Allergan plc (NYSE: AGN) announced today its Be The Difference philanthropic program supporting children and their families who may benefit from treatment with BOTOX® (onabotulinumtoxinA) for pediatric upper limb spasticity. BOTOX® is approved to treat…
BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program
DUBLIN, Feb. 3, 2020 |PRNewswire| -- Allergan plc (NYSE: AGN) announced today its Be The Difference philanthropic program supporting children and their families who may benefit from treatment with BOTOX® (onabotulinumtoxinA) for pediatric upper limb spasticity. BOTOX® is approved to treat…